Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C
Author(s) -
JoonHo Yoon,
Jong In Lee,
Soon Koo Baik,
Kwang Ho Lee,
Joon Hyung Sohn,
Hyean-Woo Lee,
Jun Namkung,
Sei Jin Chang,
Jong-Whan Choi,
Hyun-Won Kim,
Byung-Il Yeh
Publication year - 2007
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v13.i46.6236
Subject(s) - ribavirin , interferon , hepatitis c virus , medicine , virology , combination therapy , hepatitis c , genotype , alpha interferon , titer , interferon alfa , gastroenterology , immunology , virus , biology , gene , biochemistry
To confirm the predictive factors for interferon (IFN)-alpha and ribavirin combination therapy for chronic hepatitis patients with hepatitis C virus (HCV) genotype 1b.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom